Revenue
2022
2023
2024
2025
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Price$3.53Cached quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2023
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — |
| Research & development | $4.1M | $3.6M | $3.5M | $1.0M | $1.0M |
| Operating expenses | $11.9M | $7.7M | $5.9M | $2.3M | $1.7M |
| Operating income | −$11.9M | −$7.7M | −$5.9M | −$2.3M | −$1.7M |
| EBITDA | −$11.6M | −$7.7M | −$5.9M | −$2.3M | −$1.7M |
| Net income | −$11.7M | −$9.1M | −$6.6M | −$5.0M | −$1.2M |
| Basic EPSper basic share | -$7.16 | -$79.65 | -$88.25 | -$126.00 | -$24.00 |
| Diluted EPSper diluted share | -$7.16 | -$82.60 | -$88.25 | -$126.00 | — |
Owners
Reported shareholders
≈34.62%of listed shares
Brown Milton346.62K shares · Dec 31, 2024
View holders
| Holder | % owned |
|---|---|
Brown Milton | ≈34.62%346.62K shares |
Schafer Joshua | ≈20.98%210K shares |
Richards Steven M | ≈20.98%210K shares |
Scorsis George | ≈18.39%184.16K shares |
Nabyt Oleh | ≈18.39%184.16K shares |
Tung Joseph | ≈18.39%184.16K shares |
HRT FINANCIAL LP | 7.85%78.6K shares |
CITADEL ADVISORS LLC | 2.43%24.35K shares |
BARCLAYS PLC | 0.07%750 shares |
Tower Research Capital LLC (TRC) | 0.04%389 shares |
KELLEHER FINANCIAL ADVISORS | 0.01%120 shares |
Percentages use 1M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Reported positions exceed 100% in total, so the circle shows the selected holder only.
Source: SEC Form 5 ↗Updated Sep 29, 2026 · Quarterly data